RELX (BSP:R1EL34) Growth Rank

: 0 (As of Today)

View and export this data going back to 2020. Start your Free Trial

RELX has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

RELX Growth Rank Related Terms

Thank you for viewing the detailed overview of RELX's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

RELX (BSP:R1EL34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » RELX PLC (BSP:R1EL34) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

RLXXF:USA RELX:USA REN:Netherlands REL:Mexico RELl:UK REL:UK RDEB:Germany RDEB:Germany RDEB:Germany RDED:Germany RDEB:Germany

Address

1-3 Strand, London, GBR, WC2N 5JR

Website

https://www.relx.com

RELX PLC is a diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical; risk; legal; and exhibitions. It generates maximum revenue from the Scientific, Technical and Medical and Risk segment. Scientific, Technical and Medical segment provides information and analytics that help institutions and professionals progress science, advance healthcare and improve performance. Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency.

RELX (BSP:R1EL34) Headlines

No Headlines